ArticleClinical and translational medicine2023

Effectiveness of lenvatinib plus immune checkpoint inhibitors in primary advanced hepatocellular carcinoma beyond oligometastasis.

Xiao-Hui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.